Inflammatory Markers and Outcomes in Cardiovascular Disease
article has not abstract
Vyšlo v časopise:
Inflammatory Markers and Outcomes in Cardiovascular Disease. PLoS Med 6(9): e32767. doi:10.1371/journal.pmed.1000147
Kategorie:
Perspective
prolekare.web.journal.doi_sk:
https://doi.org/10.1371/journal.pmed.1000147
Souhrn
article has not abstract
Zdroje
1. TedguiA
MallatZ
2006 Cytokines in atherosclerosis: Pathogenic and regulatory pathways. Physiol Rev 86 515 581
2. Ridker PMBJ
CookNR
RifaiN
2003 C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14719 initially healthy American women. Circulation 107 391 397
3. SabatineMS
MorrowDA
JablonskiKA
RiceMM
WarnicaJW
2007 Prognostic significance of the Centers for Disease Control/American Heart Association high-sensitivity C-reactive protein cut points for cardiovascular and other outcomes in patients with stable coronary artery disease. Circulation 115 1528 1536
4. Di NapoliM
SchwaningerM
CappelliR
CeccarelliE
Di GianfilippoG
2005 Evaluation of C-reactive protein measurement for assessing the risk and prognosis in ischemic stroke: a statement for health care professionals from the CRP Pooling Project members. Stroke 36 1316 1329
5. DaneshJ
WheelerJG
HirschfieldGM
EdaS
EiriksdottirG
2004 C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N EnglJ Med 350 1387 1389
6. CookNR
2007 Use and misuse of the receiver operating characteristic curve in risk prediction. Circulation 115 928 935
7. ZetheliusB
BerglundL
SundströmJ
IngelssonE
BasuS
2008 Use of multiple biomarkers to improve the prediction of death from cardiovascular causes. N Engl J Med 358 2107 2116
8. RidkerPM
DanielsonE
FonsecaFA
GenestJ
GottoAMJr
2008 Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med 359 2195 2207
9. SattarN
MurrayH
WelshP
BlauwGJ
BuckleyBM
2009 PLoS Med 6(6) e99 Are markers of inflammation more strongly associated with risk for fatal than for nonfatal vascular events? doi:10.1371/journal.pmed.1000099
10. WhiteleyW
JacksonC
LewisS
LoweG
RumleyA
2009 Inflammatory markers and poor outcome after stroke: A prospective cohort study and systematic review of interleukin 6. PLoS Med 6(8) e145 doi:10.1371/journal.pmed.1000145
11. AudebertHJ
RottMM
EckT
HaberlH
2004 Systemic inflammatory response depends on initial stroke severity but is attenuated by successful thrombolysis. Stroke 35 2128 2133
Štítky
Interné lekárstvoČlánok vyšiel v časopise
PLOS Medicine
2009 Číslo 9
- Statiny indukovaná myopatie: Jak na diferenciální diagnostiku?
- MUDr. Dana Vondráčková: Hepatopatie sú pri liečbe metamizolom väčším strašiakom ako agranulocytóza
- Nech brouka žít… Ať žije astma!
- Vztah mezi statiny a rizikem vzniku nádorových onemocnění − metaanalýza
- Parazitičtí červi v terapii Crohnovy choroby a dalších zánětlivých autoimunitních onemocnění
Najčítanejšie v tomto čísle
- Changing Patterns of Dengue Epidemiology and Implications for Clinical Management and Vaccines
- Grading Quality of Evidence and Strength of Recommendations: A Perspective
- Inflammatory Markers and Outcomes in Cardiovascular Disease
- The GRADE System for Rating Clinical Guidelines